摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-<<(phenylmethoxy)amino>carbonyl>-3-methylbutanoate | 151927-76-3

中文名称
——
中文别名
——
英文名称
ethyl 2-<<(phenylmethoxy)amino>carbonyl>-3-methylbutanoate
英文别名
Ethyl 3-methyl-2-(phenylmethoxycarbamoyl)butanoate
ethyl 2-<<(phenylmethoxy)amino>carbonyl>-3-methylbutanoate化学式
CAS
151927-76-3
化学式
C15H21NO4
mdl
——
分子量
279.336
InChiKey
WHFTYRPTAXUJIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    20
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 2-<<(phenylmethoxy)amino>carbonyl>-3-methylbutanoate 在 palladium on activated charcoal 氢氧化钾氢气碳酸氢钠1-羟基苯并三唑N,N-二异丙基乙胺N,N'-二环己基碳二亚胺 作用下, 以 甲醇乙醇N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 70.5h, 生成 N-<2-<(hydroxyamino)carbonyl>-3-methylbutanoyl>-L-tryptophan
    参考文献:
    名称:
    Hydroxamic Acids as Potent Inhibitors of Endothelin-Converting Enzyme from Human Bronchiolar Smooth Muscle
    摘要:
    Hydroxamic acids 6a-h, derived from malonyl amino acids, and 25a-d, derived from succinyl amino acids, were synthesized as inhibitors of human bronchiolar smooth muscle endothelin-converting enzyme (HBSM ECE). Several unexpected side reactions were discovered, particularly in the synthesis of hydroxamates derived from succinates. In vitro evaluation against human bronchiolar ECE revealed that in all cases hydroxamates derived from malonate were more potent than hydroxamates derived from succinate. Isopropyl and isobutyl P-1' side chains were suitable; omission of the P-1' Side chain seriously diminished potency. In the P-2' position, several amino acids gave potent malonate-derived hydroxamate inhibitors (6b,d-h, IC50 = 0.2-6.8 nM), and beta-Ala provided an extremely potent inhibitor (6c, IC50 = 0.01 nM). C-terminus carboxylates are much more potent ECE inhibitors than the corresponding amides. Most of the hydroxamates were also potent inhibitors of thermolysin and neutral endopeptidase (NEP); however, the P-2' beta-Ala derivative 6c uniquely inhibited HBSM ECE much more potently than NEP.
    DOI:
    10.1021/jm00012a011
  • 作为产物:
    描述:
    异丙基丙二酸二乙酯 、 alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾1-羟基苯并三唑N,N'-二环己基碳二亚胺 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 69.0h, 生成 ethyl 2-<<(phenylmethoxy)amino>carbonyl>-3-methylbutanoate
    参考文献:
    名称:
    Hydroxamic Acids as Potent Inhibitors of Endothelin-Converting Enzyme from Human Bronchiolar Smooth Muscle
    摘要:
    Hydroxamic acids 6a-h, derived from malonyl amino acids, and 25a-d, derived from succinyl amino acids, were synthesized as inhibitors of human bronchiolar smooth muscle endothelin-converting enzyme (HBSM ECE). Several unexpected side reactions were discovered, particularly in the synthesis of hydroxamates derived from succinates. In vitro evaluation against human bronchiolar ECE revealed that in all cases hydroxamates derived from malonate were more potent than hydroxamates derived from succinate. Isopropyl and isobutyl P-1' side chains were suitable; omission of the P-1' Side chain seriously diminished potency. In the P-2' position, several amino acids gave potent malonate-derived hydroxamate inhibitors (6b,d-h, IC50 = 0.2-6.8 nM), and beta-Ala provided an extremely potent inhibitor (6c, IC50 = 0.01 nM). C-terminus carboxylates are much more potent ECE inhibitors than the corresponding amides. Most of the hydroxamates were also potent inhibitors of thermolysin and neutral endopeptidase (NEP); however, the P-2' beta-Ala derivative 6c uniquely inhibited HBSM ECE much more potently than NEP.
    DOI:
    10.1021/jm00012a011
点击查看最新优质反应信息

文献信息

  • US5504070A
    申请人:——
    公开号:US5504070A
    公开(公告)日:1996-04-02
  • [EN] INHIBITORS OF THE CONVERSION OF BIG ENDOTHELIN TO ENDOTHELIN
    申请人:BERLEX LABORATORIES, INC.
    公开号:WO1993011154A1
    公开(公告)日:1993-06-10
    (EN) Novel and known compounds are described which inhibit endothelin converting enzyme (ECE), thereby preventing the conversion of Big Endothelin (BET) to Endothelin (ET). Pharmaceutical usefulness and preparations are described.(FR) L'invention concerne des composés nouveaux et connus qui inhibent l'enzyme de conversion de l'endothéline, empêchant ainsi la conversion de l'endothéline ''Big'' (ETB) en endothéline (ET). Des applications et des préparation pharmaceutiques sont également décrites.
  • Hydroxamic Acids as Potent Inhibitors of Endothelin-Converting Enzyme from Human Bronchiolar Smooth Muscle
    作者:Ron Bihovsky、Barry L. Levinson、Rivka C. Loewi、Paul W. Erhardt、Mark A. Polokoff
    DOI:10.1021/jm00012a011
    日期:1995.6
    Hydroxamic acids 6a-h, derived from malonyl amino acids, and 25a-d, derived from succinyl amino acids, were synthesized as inhibitors of human bronchiolar smooth muscle endothelin-converting enzyme (HBSM ECE). Several unexpected side reactions were discovered, particularly in the synthesis of hydroxamates derived from succinates. In vitro evaluation against human bronchiolar ECE revealed that in all cases hydroxamates derived from malonate were more potent than hydroxamates derived from succinate. Isopropyl and isobutyl P-1' side chains were suitable; omission of the P-1' Side chain seriously diminished potency. In the P-2' position, several amino acids gave potent malonate-derived hydroxamate inhibitors (6b,d-h, IC50 = 0.2-6.8 nM), and beta-Ala provided an extremely potent inhibitor (6c, IC50 = 0.01 nM). C-terminus carboxylates are much more potent ECE inhibitors than the corresponding amides. Most of the hydroxamates were also potent inhibitors of thermolysin and neutral endopeptidase (NEP); however, the P-2' beta-Ala derivative 6c uniquely inhibited HBSM ECE much more potently than NEP.
查看更多